{"transactions":[{"id":2220840,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":125820,"kind":"person","name":"Levin Adam","position":1,"cik":"0001868308","reported_name":"Levin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-27T21:35:29.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 23, 2022, Mr. Levin was granted an option (the \"Stock Option\") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 23, 2022, Mr. Levin was granted an option (the \"Stock Option\") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2022, Mr. Levin was granted an option (the \"Stock Option\") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year."}],"balance_after":35000,"derivative":{"exercise_price":0.425,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-22-017869","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315222017869/ownership.xml","form_type":"4"}},{"id":2411299,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":125820,"kind":"person","name":"Levin Adam","position":1,"cik":"0001868308","reported_name":"Levin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-02-04T20:21:09.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On February 4, 2022, Mr. Levin was granted an option (the \"Stock Option\") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 4, 2022, Mr. Levin was granted an option (the \"Stock Option\") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 4, 2022, Mr. Levin was granted an option (the \"Stock Option\") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022."}],"balance_after":20000,"derivative":{"exercise_price":3.13,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-22-003213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315222003213/ownership.xml","form_type":"4"}}]}